Back to Journals » Psoriasis: Targets and Therapy » Volume 13

ESCI
Impact Factor

Psoriasis: Targets and Therapy

ISSN: 2230-326X


       

Archive: Volume 13, 2023


Review

The Skin Microbiome and Its Role in Psoriasis: A Review

Celoria V, Rosset F, Pala V, Dapavo P, Ribero S, Quaglino P, Mastorino L

Psoriasis: Targets and Therapy 2023, 13:71-78

Published Date: 26 October 2023

Review

Management of Plaque Psoriasis in Adults: Clinical Utility of Tapinarof Cream

Spencer RK, Jin JQ, Elhage KG, Davis MS, Liao W, Bhutani T

Psoriasis: Targets and Therapy 2023, 13:59-69

Published Date: 25 October 2023

Review

Palmoplantar Pustulosis: A Systematic Review of Risk Factors and Therapies

Heidemeyer K, May Lee M, Cazzaniga S, Yawalkar N, Naldi L

Psoriasis: Targets and Therapy 2023, 13:33-58

Published Date: 22 September 2023

Case report

Therapeutic Management of a Case of Severe Psoriasis Coexistent with Bullous Pemphigoid in the Elderly

Di Lernia V, Peccerillo F, Ficarelli E

Psoriasis: Targets and Therapy 2023, 13:27-31

Published Date: 22 August 2023

Review

Effectiveness and Safety of Deucravacitinib for the Management of Psoriasis: A Review of the Current Literature

Potestio L, Ruggiero A, Fabbrocini G, Martora F, Megna M

Psoriasis: Targets and Therapy 2023, 13:19-26

Published Date: 4 May 2023

Review

Safety and Efficacy of Covid-19 Vaccination in Patients Undergoing Biological Treatments for Psoriasis

Potestio L, Martora F, Fabbrocini G, Battista T, Megna M

Psoriasis: Targets and Therapy 2023, 13:11-18

Published Date: 12 April 2023

Original Research

Analysis of Drug Utilization in Patients with Psoriasis: A Real-World Retrospective Study Among the Italian Population

Perrone V, Losi S, Sabatino S, Mezzetti M, Dovizio M, Sangiorgi D, Degli Esposti L

Psoriasis: Targets and Therapy 2023, 13:1-9

Published Date: 2 March 2023